Skip to main content

. 1977 Dec;127(6):515–518.

Haloperidol-induced liver disease.

C M Fuller, S Yassinger, P Donlon, T J Imperato, B Ruebner

PMCID: PMC1237937 PMID: 595591

516

Images in this article

Figure 1.
on p.516

Figure 2.
on p.517

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Ayd F. J., Jr Haloperidol: fifteen years of clinical experience. Dis Nerv Syst. 1972 Jul;33(7):459–469. [PubMed] [Google Scholar]
Crane G. E. A review of clinical literature on haloperidol. Int J Neuropsychiatry. 1967 Aug;3(Suppl):110–127. [PubMed] [Google Scholar]
Guidelines for diagnosis of therapeutic drug-induced liver injury in liver biopsies. Lancet. 1974 May 4;1(7862):854–857. [PubMed] [Google Scholar]
McComb R. B., Bowers G. N., Jr Study of optimum buffer conditions for measuring alkaline phosphatase activity in human serum. Clin Chem. 1972 Feb;18(2):97–104. [PubMed] [Google Scholar]
McCullar F. W., Heggeness L. Limb malformations following maternal use of haloperidol. JAMA. 1975 Jan 6;231(1):62–64. doi: 10.1001/jama.231.1.62. [DOI] [PubMed] [Google Scholar]

ACTIONS

PDF (901.4 KB)

RESOURCES